Invivyd, Inc.
جودة البيانات: 100%
IVVD
NASDAQ
Manufacturing
Chemicals
KWD 1.76
▼
KWD 0.02
(-1.12%)
القيمة السوقية: 497.37 M
السعر
KWD 1.76
القيمة السوقية
497.37 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Negative free cash flow of -58.29 M
Capital efficient — spends only 0.29% of revenue on capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)110.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-77.27%
أقل من متوسط القطاع (-53.58%)
ROIC-63.00%
Net Margin-98.25%
Op. Margin-103.99%
الأمان
Debt / Equity
N/A
Current Ratio2.47
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-9.48 | -44.00
أقل من متوسط القطاع (-1.48)
P/B Ratio5.34
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1366 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1366 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.5 | -1.5 |
| P/B | 5.3 | 1.6 |
| ROE % | -77.3 | -53.6 |
| Net Margin % | -98.3 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
3 محللين
Buy
الحالي
KWD 1.76
المستهدف
KWD 10.00
KWD 10.00
KWD 10.00
KWD 10.00
التوقعات
مكرر الربحية المستقبلي
-8.00
ربحية السهم المستقبلية
-KWD 0.22
الإيرادات المقدّرة
119.67 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.22
-KWD 0.64 – KWD 0.20
|
119.67 M | 2 |
| FY2026 |
-KWD 0.23
-KWD 0.40 – -KWD 0.05
|
84.62 M | 2 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.08
-KWD 0.08 – -KWD 0.08
|
20.05 M | 1 |
| 2026 Q1 |
-KWD 0.08
-KWD 0.08 – -KWD 0.08
|
18.05 M | 1 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.10 | N/A | — |
| Q32025 | -KWD 0.10 | -KWD 0.06 | +36.8% |
| Q22025 | KWD 0.01 | -KWD 0.12 | -1300.0% |
| Q12025 | -KWD 0.01 | -KWD 0.14 | -1300.0% |
ETFs Holding This Stock
DMCRX
DMCRX
0.47% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 110.47% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 53.43 M | Net Income (TTM) | -52.49 M |
| ROE | -77.27% | ROA | -45.98% |
| Gross Margin | N/A | Operating Margin | -103.99% |
| Net Margin | -98.25% | Free Cash Flow (TTM) | -58.29 M |
| ROIC | -63.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.47 |
| Interest Coverage | N/A | Asset Turnover | 0.47 |
| Working Capital | 65.27 M | Tangible Book Value | 93.07 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9.48 | Forward P/E | -44.00 |
| P/B Ratio | 5.34 | P/S Ratio | 9.31 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3.12 | Fwd Earnings Yield | N/A |
| FCF Yield | -11.72% | ||
| Market Cap | 497.37 M | Enterprise Value | 412.40 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.30 | Revenue / Share | 0.19 |
| FCF / Share | -0.21 | OCF / Share | -0.21 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.29% | FCF Conversion | 111.05% |
| SBC-Adj. FCF | -70.23 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 53.43 M | 25.38 M | — | — | — |
| Net Income | -52.49 M | -169.93 M | -198.64 M | -241.32 M | -226.79 M |
| EPS (Diluted) | -0.30 | -1.43 | -1.81 | -2.23 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -55.56 M | -176.88 M | -212.76 M | -248.03 M | -226.91 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 38.31 M | 137.25 M | 158.66 M | 179.21 M | 182.89 M |
| SG&A Expenses | 66.93 M | 63.39 M | 49.13 M | 47.04 M | 36.52 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 276.88 M | 129.52 M | 229.18 M | 383.17 M | 620.09 M |
| Total Liabilities | 35.34 M | 61.98 M | 51.71 M | 27.20 M | 62.07 M |
| Shareholders' Equity | 241.54 M | 67.54 M | 177.47 M | 355.97 M | 558.02 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 226.69 M | 69.35 M | 200.64 M | 92.08 M | 542.22 M |
| Current Assets | 247.47 M | 100.68 M | 224.88 M | 376.92 M | 616.71 M |
| Current Liabilities | 34.16 M | 61.98 M | 50.29 M | 25.03 M | 62.06 M |
{"event":"ticker_viewed","properties":{"ticker":"IVVD","listing_kind":"stock","pathname":"/stocks/ivvd","exchange":"NASDAQ","country":"US"}}